GlassScriptPhysician profile
Kristina V Thomas
NPI 1528258449
$1,379.74
in general payments reported to CMS, 2019-2025
19 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $34.66 · 2021: $14.13 · 2022: $216 · 2023: $353 · 2024: $168 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $284.09 | 2019-2025 | Argos, Clareon, Hydrus Microstent |
| Abbvie INC. | $172.26 | 2022-2025 | |
| Ivantis, INC | $128.77 | 2019 | |
| Allergan, INC. | $123.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $103.00 | 2019-2022 | |
| Coopervision INC. | $98.46 | 2023 | Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $97.83 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $59.13 | 2023 | Iheezo |
| Regeneron Healthcare Solutions, INC. | $48.83 | 2021-2025 | Eylea Hd |
| Dompe US, INC. | $48.26 | 2024-2025 | Oxervate |
| Biotissue Holdings INC. | $46.25 | 2024-2025 | |
| Ocular Therapeutix, INC. | $33.19 | 2023 | Dextenza |
| Sight Sciences, INC. | $28.57 | 2022 | |
| Omeros Corporation | $19.37 | 2019 | |
| Apellis Pharmaceuticals, INC. | $19.12 | 2025 | Syfovre |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $18.45 | 2022 | |
| Amgen INC. | $17.88 | 2025 | Tepezza |
| Horizon Therapeutics Plc | $17.45 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.